Laurence Birch insider trades: Neopharm (NEOL.PK) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Laurence reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 12, 2009 | NEOL.PK | ↑ Buy | 36,901 | $0.04 | $2K | Direct | Mar 13, 2009 (1d) |
| Jun 3, 2008 | DATA | ↑ Buy | 5,000 | $0.54 | $3K | Direct | Jun 5, 2008 (2d) |
| May 27, 2008 | NEOL | ↑ Buy | 10,000 | $0.59 | $6K | Direct | May 29, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Laurence Birch's insider trades
Laurence Birch is President, CEO and CFO at Neopharm (NEOL.PK). Since May 27, 2008, Laurence has reported 3 open-market purchases worth $10K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (14 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEOL.PK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.